benidipine hydrochloride and its Impurities
Benidipine Hydrochloride was patented in 1981 and approved for medical use in 1991. It is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension). Reference standards of Benidipine Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
3-(3-Benzylpiperidin-1-yl) 5-(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3-(3-Benzylpiperidin-1-yl) 5-(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Catalogue No.:PA 02 95520
CAS :
2725485-58-3
Molecular Formula : C39H44N4O6
Molecular Weight : 664.79
3-(3-Benzylpiperidin-1-yl) 5-(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Dihydrochloride
3-(3-Benzylpiperidin-1-yl) 5-(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Dihydrochloride
Catalogue No.:PA 02 0951001
CAS :
NA
Molecular Formula : C39H46Cl2N4O6
Molecular Weight : 737.72
rel-3-(1-Benzylpiperidin-3-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1-nitroso-1,4-dihydropyridine-3,5-dicarboxylate
rel-3-(1-Benzylpiperidin-3-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1-nitroso-1,4-dihydropyridine-3,5-dicarboxylate
Catalogue No.:PA 02 0951002
CAS :
NA
Molecular Formula : C28H30N4O7
Molecular Weight : 534.57
